CHILDREN’S CANCER AND LEUKAEMIA GROUP
Document produced by the Chemotherapy Standardisation Group of the CCLG
For use in children and young persons under the age of 21 years treated according to CCLG clinical trials or treatment guidelines in the treatment and adjuvant therapy of childhood malignancies and associated clinical indications. The information in this summary does not extend to the use of the named product in other clinical situations.
The information in this monograph is believed to be accurate and up to date. Nonetheless it remains the responsibility of Chief Investigators to verify the information in this monograph against the protocol, and the responsibility of prescribers to check the safety of prescriptions.